Population Health Sciences

You are here

Home > Publications > Publications

Publications

Found 220 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
Journal Article
Kaur S, Silver G, Samuels S, Rosen AH, Weiss M, Mauer EA, Gerber LM, Greenwald BM, Traube C.  2020.  Delirium and Developmental Disability: Improving Specificity of a Pediatric Delirium Screen.. Pediatr Crit Care Med. 21(5):409-414.
Brandt PS, Pacheco JA, Adekkanattu P, Sholle ET, Abedian S, Stone DJ, Knaack DM, Xu J, Xu Z, Peng Y et al..  2022.  Design and validation of a FHIR-based EHR-driven phenotyping toolbox.. J Am Med Inform Assoc. 29(9):1449-1460.
Al'Aref SJ, Singh G, van Rosendael AR, Kolli KK, Ma X, Maliakal G, Pandey M, Lee BC, Wang J, Xu Z et al..  2019.  Determinants of In-Hospital Mortality After Percutaneous Coronary Intervention: A Machine Learning Approach.. J Am Heart Assoc. 8(5):e011160.
Krebs E, Enns B, Wang L, Zang X, Panagiotoglou D, Del Rio C, Dombrowski J, Feaster DJ, Golden M, Granich R et al..  2019.  Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis.. PLoS One. 14(5):e0217559.
Dubin MJ, Ilieva IP, De Deng Z-, Thomas J, Cochran A, Kravets K, Brody BD, Christos PJ, Kocsis JH, Liston C et al..  2019.  A double-blind pilot dosing study of low field magnetic stimulation (LFMS) for treatment-resistant depression (TRD).. J Affect Disord. 249:286-293.
Dubin MJ, Ilieva IP, De Deng Z-, Thomas J, Cochran A, Kravets K, Brody BD, Christos PJ, Kocsis JH, Liston C et al..  2019.  A double-blind pilot dosing study of low field magnetic stimulation (LFMS) for treatment-resistant depression (TRD).. J Affect Disord. 249:286-293.
Kapadia SN, Gulick RM.  2019.  Drug Costs: What Can Infectious Diseases Physicians Do? J Infect Dis.
Ancker JS, Mauer E, Kalish RB, Vest JR, J Gossey T.  2019.  Early Adopters of Patient-Generated Health Data Upload in an Electronic Patient Portal.. Appl Clin Inform. 10(2):254-260.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Pesko MF, Kenkel DS, Wang H, Hughes JM.  2016.  The effect of potential electronic nicotine delivery system regulations on nicotine product selection.. Addiction. 111(4):734-44.
Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al..  2020.  Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)
Brenner SK, Kaushal R, Grinspan Z, Joyce C, Kim I, Allard RJ, Delgado D, Abramson EL.  2016.  Effects of health information technology on patient outcomes: a systematic review.. J Am Med Inform Assoc. 23(5):1016-36.
Brenner SK, Kaushal R, Grinspan Z, Joyce C, Kim I, Allard RJ, Delgado D, Abramson EL.  2016.  Effects of health information technology on patient outcomes: a systematic review.. J Am Med Inform Assoc. 23(5):1016-36.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..  2020.  Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..  2020.  Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Nosyk B, Zang X, Krebs E, Enns B, Min JE, Behrends CN, Del Rio C, Dombrowski JC, Feaster DJ, Golden M et al..  2020.  Ending the HIV epidemic in the USA: an economic modelling study in six cities.. Lancet HIV.
Mullangi S, Kaushal R, Ibrahim SA.  2019.  Equity in the Age of Health Care Information Technology and Innovation: Addressing the Digital Divide.. Med Care. 57 Suppl 6 Suppl 2:S106-S107.
Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, Jeng PJ, Bayoumi AM, Kunins HV, Schackman BR.  2019.  Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.. J Subst Abuse Treat. 106:79-88.
Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, Jeng PJ, Bayoumi AM, Kunins HV, Schackman BR.  2019.  Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.. J Subst Abuse Treat. 106:79-88.
Ghomrawi HMK, Mushlin AI, Kang R, Banerjee S, Singh JA, Sharma L, Flink C, Nevitt M, Neogi T, Riddle DL.  2020.  Examining Timeliness of Total Knee Replacement Among Patients with Knee Osteoarthritis in the U.S.: Results from the OAI and MOST Longitudinal Cohorts.. J Bone Joint Surg Am. 102(6):468-476.
Varma JK, Zang C, Carton TW, Block JP, Khullar DJ, Zhang Y, Weiner MG, Rothman RL, Schenck EJ, Xu Z et al..  2023.  Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER Program.. medRxiv.